2
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Gastroparesis
1
Esophageal Motility Disorders
1
Esophageal Diseases
1
Esophageal Achalasia
1
Interventions
camrelizumab
2
Radiation
2
sintilimab
1
Tumor Burden
1
Pyloromyotomy
1
Paclitaxel
1
Ocoxin
1
Itraconazole
1
Fluorouracil
1
Esophagectomy
1
Erlotinib Hydrochloride
1
Cisplatin
1
Botulinum Toxins, Type A
1
Blood Specimen Collection
1
Biopsy
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Diseases
×
Pyloromyotomy
×
Clear all
NCT06721520
2026-02-25
EMPTY
The Cleveland Clinic
Phase 2/3
Recruiting
170 enrolled